Efficacy and Safety of Certolizumab Pegol in Japanese Patients with Moderate to Severe Plaque Psoriasis: 52 Week Results
media
posted on 2021-04-08, 09:08 authored by Adis Journals on behalf of, Yoshinori Umezawa, Akihiko Asahina, Shinichi Imafuku, Yayoi Tada, Shigetoshi Sano, Akimichi Morita, Shinya Sakurai, Naoki Hoshii, Nicola Tilt, Hidemi Nakagawa<p><strong>Article full text</strong></p><p><strong><br></strong></p><p>
The above summary slide represents the opinions of
the authors. For a full list of declarations, including funding and author
disclosure statements, please see the full text online (see “read the
peer-reviewed publication” opposite). </p>
<p>© The authors, CC-BY-NC 2021.<b>
</b></p>
History
Related Materials
- 1.
- 2.
